| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Canadian Journal of Anesthesia, Vol 45, 410-416, Copyright © 1998 by Canadian Anesthesiologists' Society
ARTICLES |
BW Brandom, OA Meretoja, E Simhi, T Taivainen, SR Wolfe, SK Woelfel, BJ Gronert and DR Cook
Department of Anesthesiology, Children's Hospital of Pittsburgh, Pennsylvania, USA. BWB+@pitt.edu
PURPOSE: This study describes the effects of 0.3 mg.kg-1 mivacurium in 180 paediatric patients between the ages of one month and 13 yr. METHODS: Alternate patients at each of two geographic sites received nitrous oxide-halothane or nitrous oxide-opioid anaesthesia. Neuromuscular blockade was monitored by electromyography (Datex NMT). Blood pressure and heart rate were recorded from an automated oscillometer. Tracheal intubation was performed 90 sec after administration of mivacurium and conditions were judged by the Krieg scale. RESULTS: There was no difference in the time course of block between anaesthetics or geographic sites. The average time to 90% block and 25% recovery was 1.0 min and 8.0 min at one month vs 2.3 min and 9.8 min at 12.5 yr of age. Intubation conditions were better during opioid (excellent in 92%) than during halothane anaesthesia (excellent in 78%) (P = 0.03). Diaphragmatic movement was less frequent in younger patients (P < 0.001). Intubation conditions did not differ between the two geographic sites. In the first minute after mivacurium, systolic and diastolic blood pressures decreased (P < 0.001) to similar extents in all patients. A transient increase in the redness of the skin of the face, trunk, and/or arms was noted during both anaesthetics (28% of infants, and 61% of children over five yr of age). CONCLUSION: The time course of block produced by mivacurium is more rapid in younger paediatric patients. The time course of mivacurium does not have the transatlantic variation which has been observed for vecuronium. Physiological changes suggestive of histamine release were frequent. Intubation conditions were very likely to be acceptable 90 sec after 0.3 mg.kg-1 mivacurium.
This article has been cited by other articles:
![]() |
E. W. Moore and J. M. Hunter The new neuromuscular blocking agents: do they offer any advantages? Br. J. Anaesth., December 1, 2001; 87(6): 912 - 925. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. W. Brandom, J. O. Margolis, G. B. Bikhazi, A. K. Ross, B. Ginsberg, G. d. L. Dear, C. A. Kenaan, J. B. Eck, S. K. Woelfel, and M. E. Lloyd Neuromuscular effects of rapacuronium in pediatric patients during nitrous oxide-halothane anesthesia: comparison with mivacurium Can J Anesth, February 1, 2000; 47(2): 143 - 149. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |